Home About Case Studies Hire Me Contact
Currently available for select engagements

Hire Social Media Manager for Biotech Startups
Senior, direct, no layers

Hire a Social Media Manager for Biotech Startups: social presence that answers questions and builds trust, built around assay development and validation.

15+
Years Experience
100+
Projects Delivered
6
Countries Served
$25M+
Revenue Enabled
Biotech Startups — Social Media Manager

A senior social media manager for biotech startups

The scarcest resource at a biotech startup is focused scientific time. Every hour a scientist spends reformatting data, chasing a CRO, or rebuilding an investor update is an hour not spent on the science the company exists to do. The recurring friction is experimental data scattered across notebooks and drives, CRO results arriving late or in unusable formats, and investor updates rebuilt from scratch every month.

Social media here is not decoration. It is the place many people check first: who is this organization, do they know their subject, and do they respond. Silence there costs enquiries.

Picture a CRO dataset arriving in a format nobody can use, days before an investor update is due. In that situation, a clear post answering the exact concern, plus a prompt reply in the comments, would turn a sceptical scroller into an enquiry. Book a free discovery call and we will test the fit on one real workflow before any wider scope is agreed.

What you get

What this engagement covers for Biotech Startups

  • A content plan for assay development and validation built from the questions research partners, investors, and CRO teams actually ask, with formats the team can sustain week after week.
  • A posting and reply routine: content published consistently, comments and messages answered promptly, and sensitive questions routed to a human.
  • Short-form explanations of CRO study management in plain language, designed for the platforms where the audience already is.
  • A review and reputation routine: encouraging honest reviews, responding to criticism gracefully, and learning from what people say.
  • Community guidelines and guardrails for regulated topics, so content stays accurate and never promises what the organization cannot deliver.
  • Monthly reporting tied to enquiries and conversations, not follower counts alone.
The systems Biotech Startups actually run

Built on your stack, not on top of it

an electronic lab notebook such as Benchling, a LIMS, bioinformatics pipelines, and CRO data portals already cover much of the work at biotech startups. What is usually missing is the routine around them: consistent handoffs, visible status, and checks that catch errors before they reach research partners, investors, and CRO teams.

Social content and replies connect to the organization's site and, where useful, to an electronic lab notebook such as Benchling so enquiries from social arrive with context instead of as bare messages. Scheduling and reporting stay in tools the team can run.

This page describes services, not scientific or regulatory advice. Research and regulatory decisions stay with the startup's qualified scientific staff. FDA IND and BLA pathways shapes what can be automated or changed, and the work is scoped to fit it rather than work around it.

How it works

From kickoff to delivery for Biotech Startups

  1. Listen first

    What research partners, investors, and CRO teams already say and ask about assay development and validation is gathered from comments, messages, and reviews before anything is posted.

  2. Plan what the team can sustain

    A content plan is built around the team's real capacity, so consistency survives past the first enthusiastic month.

  3. Publish and respond

    Content goes out on schedule, and replies are handled promptly with a human route for anything sensitive.

  4. Learn from the response

    What earns conversations and enquiries is kept; what earns only likes is changed or dropped.

Why Omer

Why hire Omer

  • Content built from real questions, not trends
  • Replies handled promptly, sensitive topics routed to humans
  • Plans the team can sustain past the first month
  • Guardrails for regulated topics
  • Reporting tied to conversations, not follower counts
Outcomes

What changes in practice

For a startup like this, success looks like scientists spending time on science, partners getting clean data, and milestones documented well enough to survive diligence.

Two problems deserve naming: experimental data scattered across notebooks and drives and CRO results arriving late or in unusable formats. Both persist when the underlying routine stays manual and nobody owns the follow-up, so each deliverable in this engagement is paired with a named owner and a visible queue, and problems surface while they are still small.

What changes is the public face: consistent, honest content, prompt replies, and a reputation that answers questions before a visitor even asks them.

Browse all hire engagements or discuss your biotech startup workflow directly.

FAQ

Questions, answered

Which platforms should we be on?
The ones where research partners, investors, and CRO teams already are and where the team can sustain a presence — usually one or two done well, not five done badly.
Who answers sensitive questions?
A human does, with a routing rule. Social content never gives individual advice it is not qualified to give.
How is social media success measured?
By conversations and enquiries, not follower counts. Reporting ties social activity to real contact.
How do you protect research data and intellectual property?
Research data stays inside the startup's own systems and approved tools, with access following existing permissions. Nothing is sent to a public tool or used to train a shared model, and social media manager work work is scoped so unpublished results and IP stay under the company's control.
What would the first project be for biotech startups?
The first project is usually one workflow — usually experiment data organization, or CRO reporting — with a clear measure such as less time spent assembling the next investor update. One workflow done well is worth more than a broad scope started everywhere at once, and the handover documentation is part of the first project, not an afterthought.
Currently available for select engagements

Ready to get started?

The best way to explore working together is a quick conversation. Reach out through your preferred channel and let us discuss your project.